Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedDifference0.9%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference1%
- Check15 days agoChange DetectedDifference0.9%
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a Phase 1/2 study for SNS-101 and the addition of a list of cancer types relevant to the study. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference31%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 12, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.9%
- Check37 days agoChange DetectedThe page has been updated to include information on Esophageal Cancer and has been revised to version 2.14.3, while information on Soft Tissue Sarcoma has been removed.SummaryDifference0.7%
Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.